Diuretics in proton pump inhibitor therapy link to hypomagnesaemia

Proton pump inhibitor (PPI) therapy is linked with hospitalisation for hypomagnesaemia, particularly among patients also receiving diuretics, according to research published this week in PLOS Medicine.  The study, conducted by David Juurlink of the University of Toronto and colleagues, suggests that physicians reconsider long-term PPI therapy for patients with a diagnosis of hypomagnesemia or concurrent use of diuretics.

To continue reading this article, please Log In or Sign Up for access.